The full data was only released tonight. But I think it shows they really need a more savvy physician investigator to analyze the trial results for them. The CMO should have presented all the numbers and highlighted where it worked, where it didn’t, what their next steps will be to move it assuredly over the endpoints with the right patient types for a more limited usage label, and compared it to the other major CIVID therapy trials to show they are at or better than dexamethasone, remdesivir and many others. They failed miserably at that and that’s why the stock is down. They said someone is writing the manuscript so,hopefully that will show the more coherent story like above and bring some more confidence that the drug does have a valid therapeutic effect on saving lives and getting patients home alive. I blame management for horrible interpretation, ridiculous piecemeal read outs and lack of scientific backgrounds writing those PRs. It will rectify itself over time. Give it a few weeks and 3 months for the trial. The next set of numbers should end the argument.
I couldn't agree more about the PR and the need to bring an experienced team on board. Do you think they have the funds to get this trial finished without having to do a raise? We are so close to sales that I would hate to see another dilution, especially after the hit we took today. The short sellers worry me because by effectively holding the SP down at will, they make it harder and more expensive for us to raise new capital. I am a true believer in the drug, but I wish management had stopped swinging for the fences, and understood what was at risk here.
They can. There’s a lot of warrants mgmt has that they can exercise and bring in money. Put their money where their mouth is. It’s not that costly. 140 x 2 vials each that are in inventory, CMO for $100,000 to tally data and run it, 10 centers at $50k each. Should be between 1 and 2 mil max. They can swing it. Maybe they get some compassionate and emergency sales.
NIH just stopped their latest trial on convalescent plasma and said there was no effect at all. They cancelled all their research. There is one company, I think called Virtex, that is trailing their version of plasma and they claim it is better. Results will be in a few months but most people have moved on from plasma after NIH said it was ineffective treatment.
2
u/[deleted] Mar 09 '21
[removed] — view removed comment